HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
3.170
+0.010 (0.32%)
At close: Feb 11, 2026, 4:00 PM EST
3.250
+0.080 (2.52%)
After-hours: Feb 11, 2026, 4:20 PM EST
HeartSciences Revenue
HeartSciences had revenue of $2.42K in the quarter ending October 31, 2025. This brings the company's revenue in the last twelve months to $8.67K, down -60.68% year-over-year. In the fiscal year ending April 30, 2025, HeartSciences had annual revenue of $4.35K, down -76.61%.
Revenue (ttm)
$8.67K
Revenue Growth
-60.68%
P/S Ratio
1,148.16
Revenue / Employee
$578
Employees
15
Market Cap
10.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 4.35K | -14.25K | -76.61% |
| Apr 30, 2024 | 18.60K | 13.45K | 261.17% |
| Apr 30, 2023 | 5.15K | -9.22K | -64.17% |
| Apr 30, 2022 | 14.37K | -11.23K | -43.86% |
| Apr 30, 2021 | 25.60K | -38.58K | -60.11% |
| Apr 30, 2020 | 64.18K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| STRATA Skin Sciences | 30.98M |
| Lifeward | 24.50M |
| Allurion Technologies | 17.21M |
| Beyond Air | 5.80M |
| Tenon Medical | 3.23M |
| Sintx Technologies | 1.27M |
| Movano | 500.00K |
| iTonic Holdings | 305.22K |
HSCS News
- 6 days ago - University of West England Adopts HeartSciences' MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center - GlobeNewsWire
- 13 days ago - Cibolo Health Designates HeartSciences' MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals - GlobeNewsWire
- 2 months ago - HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device - GlobeNewsWire
- 2 months ago - HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1 - GlobeNewsWire
- 5 months ago - HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results - GlobeNewsWire
- 6 months ago - HeartSciences Announces Conference Participation and Investor Webinar - GlobeNewsWire
- 7 months ago - HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results - GlobeNewsWire